1. Home
  2. TRAK vs CRBP Comparison

TRAK vs CRBP Comparison

Compare TRAK & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

N/A

Current Price

$7.96

Market Cap

157.2M

Sector

Technology

ML Signal

N/A

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$9.16

Market Cap

184.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRAK
CRBP
Founded
1990
2009
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
184.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
TRAK
CRBP
Price
$7.96
$9.16
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
54.5K
419.1K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
0.90%
N/A
EPS Growth
20.69
N/A
EPS
0.28
N/A
Revenue
$21,007,076.00
$4,822,272.00
Revenue This Year
$6.61
N/A
Revenue Next Year
$10.04
$116.00
P/E Ratio
$28.64
N/A
Revenue Growth
4.84
97.62
52 Week Low
$6.94
$7.12
52 Week High
$18.47
$20.56

Technical Indicators

Market Signals
Indicator
TRAK
CRBP
Relative Strength Index (RSI) 34.82 56.05
Support Level $8.11 $7.86
Resistance Level $9.09 $9.73
Average True Range (ATR) 0.28 0.44
MACD -0.09 0.01
Stochastic Oscillator 19.39 61.59

Price Performance

Historical Comparison
TRAK
CRBP

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: